362 related articles for article (PubMed ID: 15475059)
21. Preparation of a molecularly imprinted soft contact lens as a new ocular drug delivery system for dorzolamide.
Malaekeh-Nikouei B; Vahabzadeh SA; Mohajeri SA
Curr Drug Deliv; 2013 Jun; 10(3):279-85. PubMed ID: 23360228
[TBL] [Abstract][Full Text] [Related]
22. Systemic bioavailability and cardiopulmonary effects of 0.5% timolol eyedrops.
Korte JM; Kaila T; Saari KM
Graefes Arch Clin Exp Ophthalmol; 2002 Jun; 240(6):430-5. PubMed ID: 12107508
[TBL] [Abstract][Full Text] [Related]
23. [Special indications for the use of soft contact lenses as a drug-release-system (author's transl)].
Bietti GB; De Caro G; Giraldi JP; Romani E
Klin Monbl Augenheilkd; 1976 Jan; 168(1):33-43. PubMed ID: 979031
[TBL] [Abstract][Full Text] [Related]
24. Ocular mini-tablets for controlled release of timolol: evaluation in rabbits.
Chetoni P; Mariotti Bianchi L; Giannaccini B; Saettone MF; Conte U; Sangalli ME
J Ocul Pharmacol Ther; 1996; 12(3):245-52. PubMed ID: 8875330
[TBL] [Abstract][Full Text] [Related]
25. Tailored gatifloxacin Pluronic® F-68-loaded contact lens: Addressing the issue of transmittance and swelling.
Maulvi FA; Parmar RJ; Desai AR; Desai DM; Shukla MR; Ranch KM; Shah SA; Shah DO
Int J Pharm; 2020 May; 581():119279. PubMed ID: 32240806
[TBL] [Abstract][Full Text] [Related]
26. Extended Ciprofloxacin Release Using Vitamin E Diffusion Barrier From Commercial Silicone-Based Soft Contact Lenses.
Shayani Rad M; Mohajeri SA
Eye Contact Lens; 2017 Mar; 43(2):103-109. PubMed ID: 26863046
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and systemic side-effects of topical 0.5% timolol aqueous solution and 0.1% timolol hydrogel.
Uusitalo H; Niño J; Tahvanainen K; Turjanmaa V; Ropo A; Tuominen J; Kähönen M
Acta Ophthalmol Scand; 2005 Dec; 83(6):723-8. PubMed ID: 16396651
[TBL] [Abstract][Full Text] [Related]
28. Brimonidine Imprinted Hydrogels and Evaluation of Their Binding and Releasing Properties as New Ocular Drug Delivery Systems.
Omranipour HM; Sajadi Tabassi SA; Kowsari R; Rad MS; Mohajeri SA
Curr Drug Deliv; 2015; 12(6):717-25. PubMed ID: 25772151
[TBL] [Abstract][Full Text] [Related]
29. Binding site characteristics of 17beta-estradiol imprinted polymers.
Wei S; Mizaikoff B
Biosens Bioelectron; 2007 Sep; 23(2):201-9. PubMed ID: 17540554
[TBL] [Abstract][Full Text] [Related]
30. Co-delivery of timolol and hyaluronic acid from semi-circular ring-implanted contact lenses for the treatment of glaucoma: in vitro and in vivo evaluation.
Desai AR; Maulvi FA; Pandya MM; Ranch KM; Vyas BA; Shah SA; Shah DO
Biomater Sci; 2018 May; 6(6):1580-1591. PubMed ID: 29708242
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetic differences between ocular inserts and eyedrops.
Friedrich SW; Saville BA; Cheng YL; Rootman DS
J Ocul Pharmacol Ther; 1996; 12(1):5-18. PubMed ID: 8925396
[TBL] [Abstract][Full Text] [Related]
32. Controlled release of betamethasone from vitamin E-loaded silicone-based soft contact lenses.
Rad MS; Sajadi Tabassi SA; Moghadam MH; Mohajeri SA
Pharm Dev Technol; 2016 Nov; 21(7):894-899. PubMed ID: 26334597
[TBL] [Abstract][Full Text] [Related]
33. Preparation and evaluation of a contact lens vehicle for puerarin delivery.
Xu J; Li X; Sun F
J Biomater Sci Polym Ed; 2010; 21(3):271-88. PubMed ID: 20178685
[TBL] [Abstract][Full Text] [Related]
34. An interferometric method for the dynamic evaluation of the tear film.
Szczesna DH; Kasprzak HT; Jaronski J; Rydz A; Stenevi U
Acta Ophthalmol Scand; 2007 Mar; 85(2):202-8. PubMed ID: 17305735
[TBL] [Abstract][Full Text] [Related]
35. Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system.
Aggarwal D; Kaur IP
Int J Pharm; 2005 Feb; 290(1-2):155-9. PubMed ID: 15664141
[TBL] [Abstract][Full Text] [Related]
36. Intraocular pressure reduction and systemic absorption of timolol after administration of one side-coated inserts in rabbits.
Saettone MF; Chetoni P; Cappanera L; Conte U; Finne U; Järvinen K; Salivirta J; Urtti A
J Ocul Pharmacol; 1993; 9(1):1-12. PubMed ID: 8463729
[TBL] [Abstract][Full Text] [Related]
37. A mathematical model for ocular tear and solute balance.
Zhu H; Chauhan A
Curr Eye Res; 2005 Oct; 30(10):841-54. PubMed ID: 16251121
[TBL] [Abstract][Full Text] [Related]
38. Dispersion of microemulsion drops in HEMA hydrogel: a potential ophthalmic drug delivery vehicle.
Gulsen D; Chauhan A
Int J Pharm; 2005 Mar; 292(1-2):95-117. PubMed ID: 15725557
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of nicotinamide-based molecularly imprinted microspheres and in vitro controlled release studies.
Del Sole R; Lazzoi MR; Vasapollo G
Drug Deliv; 2010 Apr; 17(3):130-7. PubMed ID: 20163194
[TBL] [Abstract][Full Text] [Related]
40. Design and optimization of a novel implantation technology in contact lenses for the treatment of dry eye syndrome: In vitro and in vivo evaluation.
Maulvi FA; Shaikh AA; Lakdawala DH; Desai AR; Pandya MM; Singhania SS; Vaidya RJ; Ranch KM; Vyas BA; Shah DO
Acta Biomater; 2017 Apr; 53():211-221. PubMed ID: 28131945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
